Blog

Richard Lee: Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium

Collage Photo of Drs. Collin Weekes, Regina Brown, Luckson Mathieu and Erica Stringer-Reasor

Jun 21, 2024, 06:24

Richard Lee: Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium

Erica Stringer-Reasor, Vice Chairperson at The University of Alabama at Birmingham, shared a post by Richard Lee, Genitourinary medical oncologist at Mass General in Boston, on X:

“Thank you Dr. Colin Weekes and Mass General Cancer Center for inviting me to the Cancer Equity Colloquium to discuss the important topic of clinical trial diversification.”

The post by Richard Lee:

“Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium with Drs. Weekes, Brown, Mathieu, and Stringer-Reasor.”

Source: Erica Stringer-Reasor/X and Richard Lee/X

Brown cancer Cancer Equity Colloquium clinical trial diversification Colin Weekes Erica Stringer-Reasor Mass General Cancer Center Mathieu OncoDaily Oncology Richard Lee

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success